公众号 / 文章心脑血管急症重症综合管理与镇静镇痛

急诊科心脏移植患者管理入门

A primer for managing cardiac transplant patients in the emergency department setting.
PubMed 文献 · Am J Emerg Med · 2021-01-01
一句话结论心脏移植患者可无痛性心梗,急诊识别并发症并尽早联系移植医生是关键。

本文为叙述性综述,聚焦心脏移植患者急诊评估与管理。移植心脏解剖生理不同于自体心脏,第一年内移植物衰竭、排斥和感染是常见致残致死原因。患者因免疫抑制感染风险高,但免疫抑制不足增加急性排斥风险。可发生房颤、室性心律失常、急性冠脉综合征、心脏移植血管病变和药物不良反应;急性冠脉综合征可表现为「无痛性」心梗。建议有条件时咨询移植医生协助评估管理。

要点

  • 心脏移植患者急性冠脉综合征可表现不典型,出现所谓「无痛性」心肌梗死,急诊须警惕。
  • 移植后第一年内移植物衰竭、排斥和感染是常见致残致死原因。
  • 免疫抑制治疗增加感染风险,但免疫抑制不足增加急性排斥风险,需平衡评估。
  • 可发生房颤和室性心律失常等多种心律失常,需在急诊识别处理。
  • 有条件时建议咨询移植医生,协助评估和管理心脏移植患者。

适用人群与场景

  • 心脏移植后因移植相关并发症或疾病表现改变而就诊于急诊的患者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 有条件时咨询移植医生,协助心脏移植患者的评估和管理。
  • 原文未提及具体药物剂量、给药途径或疗程。

红旗征与不能漏的情况

  • 急性冠脉综合征可表现为「无痛性」心肌梗死,需警惕不能漏诊。
  • 移植物衰竭、排斥和感染是移植后第一年内常见致残致死原因。
  • 免疫抑制不足增加急性排斥风险,需评估。
  • 可发生房颤和室性心律失常等心律失常。
  • 心脏移植血管病变和药物不良反应也需警惕。

研究设计与关键结果

  • 研究类型为叙述性综述,旨在提供心脏移植患者及其并发症评估与管理的聚焦指南。

证据类型、等级与局限

  • 证据类型为叙述性综述,原文未提及证据等级或推荐强度。
  • 局限:叙述性综述,非系统评价,原文未提及具体检索策略或证据分级。

对床旁实践的改变

  • 急诊医生应了解心脏移植患者可表现不典型,如「无痛性」心肌梗死,避免漏诊急性冠脉综合征。
  • 对心脏移植患者应评估感染与排斥的平衡,免疫抑制不足增加急性排斥风险。
  • 有条件时尽早咨询移植医生协助评估和管理。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Cardiac transplant is an effective long-term management option for several severe cardiac diseases. These cardiac transplant patients may present to the emergency department with a range of issues involving the cardiac transplantation, including complications due to their transplant as well as altered presentations of disease resulting from their transplant.

OBJECTIVE: This narrative review provides a focused guide to the evaluation and management of patients with cardiac transplantation and its complications.

DISCUSSION: Cardiac transplant is an effective therapy for end-stage heart failure. A transplanted heart varies both anatomically and physiologically from a native heart. Several significant complications may occur. Graft failure, rejection, and infection are common causes of morbidity and mortality within the first year of transplant. As these patients are on significant immunosuppressive medication regimens, they are at risk of infection, but inadequate immunosuppression increases the risk of acute rejection. A variety of dysrhythmias such as atrial fibrillation and ventricular dysrhythmias may occur. These patients are also at risk of acute coronary syndrome, cardiac allograft vasculopathy, and medication adverse events. Importantly, patients with acute coronary syndrome can have an altered presentation with the so-called "painless" myocardial infarction. Consultation with the transplant physician is recommended, if available, for these patients to assist in evaluation and management.

CONCLUSIONS: An understanding of the presentations and various complications that may affect patients with cardiac transplant will assist emergency clinicians in the care of these patients.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Long B, Brady WJ, Gragossian A, et al. A primer for managing cardiac transplant patients in the emergency department setting. Am J Emerg Med. 2021. PMID: 33440325. doi:10.1016/j.ajem.2020.12.071

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。